MATERIAL and METHOD

Reagents and cell lines
Cisplatin-deriven cell death assay
RESULTS
Effects of cisplatin on chemosensitive and chemoresistant ovarian cancer cells viability
Two well-characterized ovarian cancer cell lines were used to investigate the effects of cisplatin on tumor cell death. The ovarian tumor cells were treated with different concentrations of cisplatin and cultured for 24 h. Cell death was detected based on 7-AAD staining. The population of live and dead cells was distinguished by flow cytometry analysis. Our data showed that more than 50% of chemosensitive, A2780, cells were killed following 50 µM of cisplatin treatment. In contrast, only 8% of A2780-AD cells died at the same cisplatin concentration. Majority of A2780 cells were killed following 100 µM cisplatin treatment, however greater than 80% of A2780-AD cells remained viable after 100 µM cisplatin treatment (Figure 1 ). The data revealed that most of A2780-AD cells remain viable following a high dose of cisplatin treatment, however the drug sensitive A2780 cells start to die following low dose drug exposure.
Sub-lethal ionizing radiation upregulates expression of some death receptors in resistant ovarian cancer cells
Suppression of some members of death receptors was observed in variety of cancer cell lines (14, 15) and we have recently observed that some member of TNFRSF (DR4 and FAS) are suppressed in resistant ovarian cancer cells (12) . To determine whether suppressed FAS and DR4 surface expressions can be reversed by sub-lethal radiation, cell surface expressions of FAS and DR4 were investigated following 0, 2 or 5 Gy irradiation of chemoresistant cells. Radiation treatment did not cause any alterations in the surface expression of DR5 on the resistant cells because DR5 was already highly expressed on A2780-AD cells (Figure 2a) . In contrast to DR5 expression, both 2 Gy and 5 Gy treatments significantly increased FAS and DR4 surface protein expressions in chemoresistant ovarian cancer cells (Figure 2b-c) . Overall, our data indicate that sublethal ionizing radiation had significant effect on expression of FAS and DR4 in drug resistant ovarian cancer cells. 
Radiation treatment enhanced sensitivity of resistant cells to killing through TRAIL and FASL receptors
Our data clearly demonstrate that sub-lethal ionizing radiation enhances expression of FAS and DR4 on chemoresistant ovarian cancer cells. To determine whether increased expression of FAS and DR4 on chemoresistant ovarian cancer cells by sublethal radiation is functional, A2780-AD cells were control-irradiated (0 Gy), irradiated with 2 Gy or 5 Gy. Following irradiation, cells were re-cultured in a fresh media for 48 h. Tumor cells were then incubated with recombinant TRAIL protein or agonistic anti-FAS antibody for 3 h to induce apoptosis in the tumor cells. The percentage of apoptotic cells was determined by quantification of activated caspase-3 using a flow cytometer. Irradiation significantly sensitized A2780-AD cells to killing by both TRAIL and anti-FAS treatments (Figure 3) . Although, 2 Gy or 5 Gy sub-lethal ionizing radiation caused some background killing of tumor cells, the percentage of active caspase-3 was significantly increased following TRAIL or anti-FAS treatment. These data suggest that the radiation can be used as an impactful tool on sensitization of resistant ovarian cancer cells to TRAIL and FAS mediated apoptosis. 
DISCUSSION
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